June 19, 2017
Ottawa, August 4, 2017 The following statement can be attributed to Pamela Fralick, President, Innovative Medicines Canada. “Innovative Medicines Canada and its member companies support policies and practices that place […]
Research Provided by QuintilesIMS.
Consultation Document, Protecting Canadians from Excessive Drug Prices Patented Medicine Prices Review Board (PMPRB) and the Patented Medicines Regulations Innovative Medicines Canada is the national voice of Canada’s innovative pharmaceutical […]
For more than a century, Canada has been at the forefront of medical innovation. From the discovery of insulin to advances in stem cell research, Canadians have made significant scientific […]
Innovative Medicines Canada welcomes the life sciences strategy, the positioning of Quebec and continued work to improve access to medicines for Quebec patients. Montreal, May 5, 2017 – Innovative Medicines Canada […]
